Brief: Glorious Finance Says Has 42.54% Stake In Cytomed Therapeutics Ltd As Of April 14 - SEC Filing
21/04/2023 20:57
April 21 (Reuters) - CytoMed Therapeutics Ltd GDTC.O :
* GLORIOUS FINANCE LIMITED SAYS HAS 42.54% STAKE IN CYTOMED
THERAPEUTICS LTD AS OF APRIL14, 2023 - SEC FILING
Further company coverage: GDTC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million